Uterine artery occlusion and myomectomy for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section

Jui Yu Lin, Wen Ling Lee, Peng Hui Wang, Man Jung Lai, Wen Hsun Chang, Wei-Min Liu

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Aim: To evaluate the efficacy of uterine artery occlusion and myomectomy (UAO+M) for pregnant women with uterine leiomyomas who are undergoing cesarean section (CS). Methods: Seventy-two women with uterine leiomyomas undergoing CS for obstetrical reasons were enrolled into this case-control study. Thirty-six patients underwent UAO+M during CS (UAO+M group), and 36 received CS alone (Control group). The UAO+M procedure was performed immediately after closure of the uterine incision wound. The outcome was measured by comparing surgical techniques, and future surgical intervention (myomectomy, uterine vessel occlusion or hysterectomy) for symptomatic leiomyoma. Results: The average follow-up time was 63 months. General characteristics of the patients were similar in both groups. There were no statistical differences in intraoperative blood loss, postoperative recovery, complications, or wound pain between the two groups. The operative time was significantly longer in the UAO+M group compared with that in the Control group, but the further surgical intervention rate was significantly lower in the UAO+M group than in the Control group (2.8% vs 41.7%, P <0.001). Seven patients (19%) in the UAO+M group and five (14%) in the Control group had a repeat CS during the follow-up period. Conclusion: UAO+M could be considered for treating pregnant women with uterine leiomyomas who are undergoing CS, compared with observation, as this procedure can minimize the necessity for future surgery, with increased operative time for the UAO+M procedure, but without increased surgical morbidity.

Original languageEnglish
Pages (from-to)284-290
Number of pages7
JournalJournal of Obstetrics and Gynaecology Research
Volume36
Issue number2
DOIs
Publication statusPublished - Apr 2010

Fingerprint

Uterine Myomectomy
Uterine Artery
Leiomyoma
Cesarean Section
Pregnant Women
Control Groups
Operative Time
Repeat Cesarean Section
Therapeutics
Wounds and Injuries
Hysterectomy
Case-Control Studies
Observation
Morbidity
Pain

Keywords

  • Cesarean section
  • Fibroids
  • Leiomyomas
  • Myomectomy
  • Uterine artery occlusion

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Uterine artery occlusion and myomectomy for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section. / Lin, Jui Yu; Lee, Wen Ling; Wang, Peng Hui; Lai, Man Jung; Chang, Wen Hsun; Liu, Wei-Min.

In: Journal of Obstetrics and Gynaecology Research, Vol. 36, No. 2, 04.2010, p. 284-290.

Research output: Contribution to journalArticle

@article{8184f27ad2e24b03ab620a1f35f90f28,
title = "Uterine artery occlusion and myomectomy for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section",
abstract = "Aim: To evaluate the efficacy of uterine artery occlusion and myomectomy (UAO+M) for pregnant women with uterine leiomyomas who are undergoing cesarean section (CS). Methods: Seventy-two women with uterine leiomyomas undergoing CS for obstetrical reasons were enrolled into this case-control study. Thirty-six patients underwent UAO+M during CS (UAO+M group), and 36 received CS alone (Control group). The UAO+M procedure was performed immediately after closure of the uterine incision wound. The outcome was measured by comparing surgical techniques, and future surgical intervention (myomectomy, uterine vessel occlusion or hysterectomy) for symptomatic leiomyoma. Results: The average follow-up time was 63 months. General characteristics of the patients were similar in both groups. There were no statistical differences in intraoperative blood loss, postoperative recovery, complications, or wound pain between the two groups. The operative time was significantly longer in the UAO+M group compared with that in the Control group, but the further surgical intervention rate was significantly lower in the UAO+M group than in the Control group (2.8{\%} vs 41.7{\%}, P <0.001). Seven patients (19{\%}) in the UAO+M group and five (14{\%}) in the Control group had a repeat CS during the follow-up period. Conclusion: UAO+M could be considered for treating pregnant women with uterine leiomyomas who are undergoing CS, compared with observation, as this procedure can minimize the necessity for future surgery, with increased operative time for the UAO+M procedure, but without increased surgical morbidity.",
keywords = "Cesarean section, Fibroids, Leiomyomas, Myomectomy, Uterine artery occlusion",
author = "Lin, {Jui Yu} and Lee, {Wen Ling} and Wang, {Peng Hui} and Lai, {Man Jung} and Chang, {Wen Hsun} and Wei-Min Liu",
year = "2010",
month = "4",
doi = "10.1111/j.1447-0756.2009.01158.x",
language = "English",
volume = "36",
pages = "284--290",
journal = "Journal of Obstetrics and Gynaecology Research",
issn = "1341-8076",
publisher = "Wiley/Blackwell (10.1111)",
number = "2",

}

TY - JOUR

T1 - Uterine artery occlusion and myomectomy for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section

AU - Lin, Jui Yu

AU - Lee, Wen Ling

AU - Wang, Peng Hui

AU - Lai, Man Jung

AU - Chang, Wen Hsun

AU - Liu, Wei-Min

PY - 2010/4

Y1 - 2010/4

N2 - Aim: To evaluate the efficacy of uterine artery occlusion and myomectomy (UAO+M) for pregnant women with uterine leiomyomas who are undergoing cesarean section (CS). Methods: Seventy-two women with uterine leiomyomas undergoing CS for obstetrical reasons were enrolled into this case-control study. Thirty-six patients underwent UAO+M during CS (UAO+M group), and 36 received CS alone (Control group). The UAO+M procedure was performed immediately after closure of the uterine incision wound. The outcome was measured by comparing surgical techniques, and future surgical intervention (myomectomy, uterine vessel occlusion or hysterectomy) for symptomatic leiomyoma. Results: The average follow-up time was 63 months. General characteristics of the patients were similar in both groups. There were no statistical differences in intraoperative blood loss, postoperative recovery, complications, or wound pain between the two groups. The operative time was significantly longer in the UAO+M group compared with that in the Control group, but the further surgical intervention rate was significantly lower in the UAO+M group than in the Control group (2.8% vs 41.7%, P <0.001). Seven patients (19%) in the UAO+M group and five (14%) in the Control group had a repeat CS during the follow-up period. Conclusion: UAO+M could be considered for treating pregnant women with uterine leiomyomas who are undergoing CS, compared with observation, as this procedure can minimize the necessity for future surgery, with increased operative time for the UAO+M procedure, but without increased surgical morbidity.

AB - Aim: To evaluate the efficacy of uterine artery occlusion and myomectomy (UAO+M) for pregnant women with uterine leiomyomas who are undergoing cesarean section (CS). Methods: Seventy-two women with uterine leiomyomas undergoing CS for obstetrical reasons were enrolled into this case-control study. Thirty-six patients underwent UAO+M during CS (UAO+M group), and 36 received CS alone (Control group). The UAO+M procedure was performed immediately after closure of the uterine incision wound. The outcome was measured by comparing surgical techniques, and future surgical intervention (myomectomy, uterine vessel occlusion or hysterectomy) for symptomatic leiomyoma. Results: The average follow-up time was 63 months. General characteristics of the patients were similar in both groups. There were no statistical differences in intraoperative blood loss, postoperative recovery, complications, or wound pain between the two groups. The operative time was significantly longer in the UAO+M group compared with that in the Control group, but the further surgical intervention rate was significantly lower in the UAO+M group than in the Control group (2.8% vs 41.7%, P <0.001). Seven patients (19%) in the UAO+M group and five (14%) in the Control group had a repeat CS during the follow-up period. Conclusion: UAO+M could be considered for treating pregnant women with uterine leiomyomas who are undergoing CS, compared with observation, as this procedure can minimize the necessity for future surgery, with increased operative time for the UAO+M procedure, but without increased surgical morbidity.

KW - Cesarean section

KW - Fibroids

KW - Leiomyomas

KW - Myomectomy

KW - Uterine artery occlusion

UR - http://www.scopus.com/inward/record.url?scp=77950264856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950264856&partnerID=8YFLogxK

U2 - 10.1111/j.1447-0756.2009.01158.x

DO - 10.1111/j.1447-0756.2009.01158.x

M3 - Article

C2 - 20492378

AN - SCOPUS:77950264856

VL - 36

SP - 284

EP - 290

JO - Journal of Obstetrics and Gynaecology Research

JF - Journal of Obstetrics and Gynaecology Research

SN - 1341-8076

IS - 2

ER -